HRA-26600-56380
3 vaccinations
3 coded responses
31 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 481 / MI
- Registered
- 2021-05-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-19
Registered in v-safe
-
2021-05-19
Dose 1 — Pfizer-BioNTech
- 2021-05-19
-
2021-05-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-21
- 2021-05-22
- 2021-05-23
- 2021-05-24
- 2021-05-25
- 2021-05-26
- 2021-06-02
-
2021-06-09
Dose 2 — Pfizer-BioNTech
- 2021-06-09
-
2021-06-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-06-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-06-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-06-13
- 2021-06-14
- 2021-06-15
- 2021-06-16
- 2021-06-25
- 2021-06-30
- 2021-07-07
- 2021-07-14
- 2021-07-23
-
2021-09-08
Survey response — 3 months, dose 2MedDRA: Oropharyngeal pain, Rash, Rhinorrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sore throat, runny nose, rashMedDRA releases: 2024-11 · check-in free text available
-
2021-09-08
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-14
- 2021-12-10
- 2022-06-10
-
2022-07-05
Dose 3 — Pfizer-BioNTech
- 2022-07-24
-
2022-07-26
Survey response — day 21, dose 3MedDRA: Gastrointestinal tract irritation — Feeling: FairFree text: GI irritationMedDRA releases: 2024-11 · check-in free text available
- 2022-08-02
- 2022-08-09
- 2022-08-16
-
2022-10-04
Survey response — 3 months, dose 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-19 | Pfizer-BioNTech | |
| 2 | 2021-06-09 | Pfizer-BioNTech | |
| 3 | 2022-07-05 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 3 months, dose 2
Symptoms: Sore throat, runny nose, rash
Release 12 — day 21, dose 3
Symptoms: GI irritation
Release 12 — 3 months, dose 3
Symptoms: Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastrointestinal tract irritation | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release